182 related articles for article (PubMed ID: 7808056)
1. Insights into the pathogenesis and prevention of coronary artery disease.
O'Keefe JH; Lavie CJ; McCallister BD
Mayo Clin Proc; 1995 Jan; 70(1):69-79. PubMed ID: 7808056
[TBL] [Abstract][Full Text] [Related]
2. Women, lipoproteins and cardiovascular disease risk.
LaRosa JC
Can J Cardiol; 1990 May; 6 Suppl B():23B-29B. PubMed ID: 2188715
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologic treatment of type 2 diabetic dyslipidemia.
Moon YS; Kashyap ML
Pharmacotherapy; 2004 Dec; 24(12):1692-713. PubMed ID: 15585439
[TBL] [Abstract][Full Text] [Related]
4. Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid--a position paper developed by the European Consensus Panel on HDL-C.
Chapman MJ; Assmann G; Fruchart JC; Shepherd J; Sirtori C;
Curr Med Res Opin; 2004 Aug; 20(8):1253-68. PubMed ID: 15324528
[TBL] [Abstract][Full Text] [Related]
5. Lipids as a coronary risk factor: analysis of hyperlipidaemias.
Hamsten A
Postgrad Med J; 1993; 69 Suppl 1():S8-11. PubMed ID: 8497457
[TBL] [Abstract][Full Text] [Related]
6. Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes.
Abdel-Maksoud M; Sazonov V; Gutkin SW; Hokanson JE
J Cardiovasc Pharmacol; 2008 Apr; 51(4):331-51. PubMed ID: 18427276
[TBL] [Abstract][Full Text] [Related]
7. The role of dietary oxidized cholesterol and oxidized fatty acids in the development of atherosclerosis.
Staprans I; Pan XM; Rapp JH; Feingold KR
Mol Nutr Food Res; 2005 Nov; 49(11):1075-82. PubMed ID: 16270280
[TBL] [Abstract][Full Text] [Related]
8. Atherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches.
Chapman MJ; Guérin M; Bruckert E
Eur Heart J; 1998 Feb; 19 Suppl A():A24-30. PubMed ID: 9519339
[TBL] [Abstract][Full Text] [Related]
9. [Modified low-density lipoprotein].
Yoshida H; Nakamura H
Nihon Rinsho; 1994 Dec; 52(12):3090-5. PubMed ID: 7853694
[TBL] [Abstract][Full Text] [Related]
10. Diet, lipids, and coronary heart disease.
Stone NJ
Endocrinol Metab Clin North Am; 1990 Jun; 19(2):321-44. PubMed ID: 2162770
[TBL] [Abstract][Full Text] [Related]
11. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
[TBL] [Abstract][Full Text] [Related]
12. The effect of dietary fat, antioxidants, and pro-oxidants on blood lipids, lipoproteins, and atherosclerosis.
Kwiterovich PO
J Am Diet Assoc; 1997 Jul; 97(7 Suppl):S31-41. PubMed ID: 9216565
[TBL] [Abstract][Full Text] [Related]
13. Niacin as a component of combination therapy for dyslipidemia.
Miller M
Mayo Clin Proc; 2003 Jun; 78(6):735-42. PubMed ID: 12934785
[TBL] [Abstract][Full Text] [Related]
14. [Role of small dense low-density lipoprotein in coronary artery disease patients with normal plasma cholesterol levels].
Koba S; Hirano T; Sakaue T; Sakai K; Kondo T; Yorozuya M; Suzuki H; Murakami M; Katagiri T
J Cardiol; 2000 Dec; 36(6):371-8. PubMed ID: 11190580
[TBL] [Abstract][Full Text] [Related]
15. The small, dense LDL phenotype and the risk of coronary heart disease: epidemiology, patho-physiology and therapeutic aspects.
Lamarche B; Lemieux I; Després JP
Diabetes Metab; 1999 Sep; 25(3):199-211. PubMed ID: 10499189
[TBL] [Abstract][Full Text] [Related]
16. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
Oki JC
Pharmacotherapy; 1995; 15(3):317-37. PubMed ID: 7667166
[TBL] [Abstract][Full Text] [Related]
17. Hypertriglyceridemia: a review of clinical relevance and treatment options: focus on cerivastatin.
Breuer HW
Curr Med Res Opin; 2001; 17(1):60-73. PubMed ID: 11464448
[TBL] [Abstract][Full Text] [Related]
18. Statins and diabetes.
Carmena R; Betteridge DJ
Semin Vasc Med; 2004 Nov; 4(4):321-32. PubMed ID: 15861314
[TBL] [Abstract][Full Text] [Related]
19. Remnant-like lipoprotein particles as risk factors for coronary artery disease in elderly patients.
Inoue T; Uchida T; Kamishirado H; Takayanagi K; Hayashi T; Morooka S; Saniabadi AR; Nakajima K
Horm Metab Res; 2004 May; 36(5):298-302. PubMed ID: 15156409
[TBL] [Abstract][Full Text] [Related]
20. Effects of two lipid-lowering, carotenoid-controlled diets on the oxidative modification of low-density lipoproteins in free-living humans.
Ahuja KD; Ashton EL; Ball MJ
Clin Sci (Lond); 2003 Sep; 105(3):355-61. PubMed ID: 12780345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
